久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Riding opportunities in 'huge unmet needs'

By Zhun Wenqian | China Daily | Updated: 2017-03-31 08:22

Riding opportunities in 'huge unmet needs'

David Ricks, CEO of US pharmaceutical company Eli Lilly and Co. [Photo provided to China Daily]

David Ricks shapes US-based pharmaceutical giant Eli Lilly's China market strategy involving local partnerships, focus on chronic conditions

David Ricks is a pharma battle-scarred veteran, having been with Eli Lilly and Co for 20 years. Before he rose to CEO this year, he spent long, sensitive years heading the US giant's bio-medicine business when it faced patent expirations on key medicines.

"That period significantly reduced our revenues, but we had a great team that worked through the challenge," he said.

"Today the bio-medicine business is growing again with new medicines in immunology and more potential medicines in late-stage development."

One of the world's oldest pharmaceutical firms, Lilly established its China branch in Shanghai in 1918. Now China serves as one of its top three markets, besides the United States and Japan. The CEO said the company is firmly committed to China and plans to further strengthen its presence in the country.

Recently, he spoke to China Daily about its expansion plans in the mainland and other emerging opportunities. The following are edited excerpts from the interview:

Do you have confidence in the China market? How do you view your growth potential in China?

The Chinese pharmaceutical market is one of the largest in the world and it continues to grow at a healthy pace. We are optimistic about the development of the China region.

We will focus on our existing product portfolio, particularly in chronic diseases, such as cancer and diabetes, where we have a competitive edge in the China market. The growth of these two markets is remarkably rapid, due to the aging population and urbanization in China. There are huge unmet needs, which bring huge opportunities for Lilly in China.

Lilly China expects to launch around 31 new compounds and new indications within 10 years, including 11 in oncology, eight in diabetes and cardiovascular and 12 in our bio-medicines organization.

Do you have any investment plans in China in the next few years?

Lilly's strategic priorities for 2020 are to build a network of China partnerships, engage and develop people, lead in ethics and compliance, transform promotional models and focus on execution excellence, maintain and accelerate access.

We remain focused on implementing our growth plans, which include building a new insulin cartridge-filling plant in Suzhou, Jiangsu province, with an investment of 2 billion yuan ($290 million). We will also expand external alliances with different partners, such as Innovent, Wuxi AppTec, Hutchison.

Do you plan to increase your R&D efforts in China?

We have internal work and external partnerships at every stage of the R&D process and our focus is to speed up access to available innovation in China. Our R&D center in Shanghai focuses on diabetics in China and exploring new fields of treatments in diabetes.

Besides, our Shanghai-based Lilly Asia Ventures was launched in 2008 and it is one of the most active life science investors in China with 30 active portfolio companies. It has built a great portfolio in both life science services and biotech. It is also the only pharma corporate venture capital investor with a local presence. This year, we're looking toward to close our Lilly Asia Ventures Fund IV.

We are encouraged by the recent signs of improvements at China's Food and Drug Administration and we look forward to partnering with Chinese authorities to further accelerate new cures for Chinese patients. Our business model is to provide new and innovative medicines to patients, rather than profiting from drugs with expired patents.

Do you have any expansion plans or business strategies in accordance with the Belt and Road Initiative?

We have been paying close attention to the development of the Belt and Road Initiative and we have been glad to see the major achievements made to date. We will let you know when our plans can be disclosed.

What's your view on the impact of globalization?

Lilly is a global company. In fact, about half of our business is outside the US. For some time now, I've been directly involved in the company's efforts on trade. We believe that healthy trade agreements create a gateway for innovation and collaboration. That requires balanced, win-win trade agreements that protect intellectual property and ensure fair and transparent regulation and access to the market. Such agreements, in turn, help innovators like Lilly more efficiently create and deliver products that enhance life.

What was your biggest achievement in China when you served as general manager there?

Elevating China to a top corporate priority and driving investment and growth. When I arrived in China in 2008, China had been managed as part of an Asian region and managed for shorter-term results. We were able to change both of those things.

What's your management style like?

Leadership for me is based on a shared purpose. Building a team that has high degrees of trust and honesty is core to creating a shared commitment to our goals. As a coach of top executives, I believe that everyone can improve and we are all capable of much more than we think, so I maintain a high level of support. But I also have high expectations of my teammates. I also believe that one has to lead by example when things get hard-this is not only required for leadership but also for strengthening team trust.

What's the best way to break the ice with Chinese businessmen?

People are people around the world and it's critical to connect on a personal level. Sharing a meal and a drink, understanding where we are both from and what we have in common, are always successful methods for me.

How do you handle hardships and setbacks?

Disappointments and risks are part of our business. The most important thing is to learn from mistakes and avoid repeating them. I try to look for the lessons rather than dwell on the disappointment and, while accountability is an important value, try to determine whether our team leaders made well-informed decisions and whether execution was sound.

We can learn from each of these steps-and sometimes in the difficult business of drug discovery, we can do virtually everything under our control extremely well and still fail. Disease can be a challenging opponent. But if we look forward, persist and adapt, we often find a way to improve the lives of patients.

How do you spend the weekend amid your busy schedule? What are your hobbies?

I enjoy the outdoors and spending time with my family. My wife and I have two sons and a daughter. With two kids in high school and a fifth-grader, when I'm not at work I'm mostly a dad-watching soccer games and cross-country meets and taking Scouts on backpacking trips.

What kind of a green lifestyle do you have?

My favorite leisure activities are outdoors and I have a personal reverence for the natural world. I'm proud to work for a company that's committed to environmental stewardship and sustainability in our operations. Making medicines requires the use of valuable resources such as energy, water and raw materials. Lilly takes a broad approach to understanding and managing our environmental impact and we're continuously looking for ways to improve our performance, like increasing energy efficiency and reducing greenhouse gas emissions.

CV

Age: 49

Career:

2017 onwards: President and CEO of Eli Lilly

2012-2016: President of Lilly Bio-Medicines

2009-2012: President and general manager of Lilly USA

2008-2009: President and general manager of Lilly China

2005-2008: General manager of Lilly Canada

Education:

1996: MBA from Indiana University;

1990: BS from Purdue University

Family: Married with three children

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    东方aⅴ免费观看久久av| 欧美成人一区二区三区| 亚洲主播在线观看| 欧美日韩免费一区二区三区 | 久久奇米777| 国产91色综合久久免费分享| 亚洲欧洲在线观看av| 色婷婷久久一区二区三区麻豆| 亚洲国产精品影院| 欧美一卡二卡在线| 国产成人精品一区二区三区四区 | 美美哒免费高清在线观看视频一区二区 | 91丝袜美腿高跟国产极品老师 | 欧美一区二区三区在线观看视频| 精品综合免费视频观看| 国产日韩精品一区二区三区在线| 97久久超碰国产精品| 天堂成人免费av电影一区| 欧美成人精品1314www| 国产91精品露脸国语对白| 伊人开心综合网| 日韩免费在线观看| 丁香另类激情小说| 欧美美女一区二区| 欧美国产精品v| 在线欧美日韩国产| 精东粉嫩av免费一区二区三区| 国产精品久久久久久久岛一牛影视| 在线精品视频一区二区三四 | 成人精品高清在线| 亚洲成人精品影院| 欧美激情一区在线观看| 在线观看欧美精品| 韩国在线一区二区| 亚洲综合视频网| 国产无人区一区二区三区| 欧美吻胸吃奶大尺度电影| 激情小说欧美图片| 亚洲一区国产视频| 久久亚洲二区三区| 欧美性淫爽ww久久久久无| 国产美女精品一区二区三区| 一区二区在线观看视频在线观看| 久久综合九色欧美综合狠狠| 欧洲激情一区二区| 国产a区久久久| 日韩高清不卡一区二区三区| 国产精品色哟哟| 欧美成人乱码一区二区三区| 欧美在线制服丝袜| 成人高清av在线| 久久精品国产精品亚洲精品| 亚洲激情六月丁香| 国产欧美日韩视频一区二区| 欧美一区二区成人| 欧亚一区二区三区| 懂色av中文一区二区三区| 日韩—二三区免费观看av| 亚洲摸摸操操av| 久久精品一区二区| 日韩欧美一二三区| 在线免费不卡电影| 成人av在线播放网站| 国产综合色视频| 日本系列欧美系列| 亚洲午夜一区二区| 亚洲欧洲性图库| 国产午夜亚洲精品理论片色戒| 91精品国产综合久久精品图片| 色屁屁一区二区| 成人天堂资源www在线| 久久不见久久见中文字幕免费| 婷婷综合五月天| 亚洲综合丁香婷婷六月香| 中文字幕不卡三区| 26uuu国产一区二区三区| 6080国产精品一区二区| 欧美影院一区二区| 色美美综合视频| 91网站最新地址| www..com久久爱| 成人免费看片app下载| 国产成人亚洲综合a∨猫咪| 久久精品久久久精品美女| 日韩精品国产精品| 亚洲成人免费视| 亚洲v中文字幕| 亚洲第四色夜色| 亚洲一级在线观看| 一级日本不卡的影视| 国产精品美女久久福利网站| 国产亚洲午夜高清国产拍精品| 欧美电视剧免费全集观看| 欧美一区二区三区小说| 欧美久久久久久久久久| 在线不卡a资源高清| 欧美日韩在线一区二区| 欧美日韩性生活| 欧美人动与zoxxxx乱| 欧美日韩精品免费| 欧美日韩中文字幕精品| 欧美日韩中文国产| 777久久久精品| 日韩欧美区一区二| 日韩免费电影网站| 精品国产一区二区三区av性色| 精品国产自在久精品国产| 欧美va亚洲va| 2014亚洲片线观看视频免费| 国产午夜三级一区二区三| 中文字幕高清不卡| 中文字幕在线不卡一区二区三区| 专区另类欧美日韩| 亚洲制服丝袜一区| 亚洲不卡在线观看| 蜜桃av一区二区三区| 国内久久精品视频| 国产成人精品一区二| 99精品在线免费| 在线观看亚洲a| 91精品国产色综合久久| 2023国产精品自拍| 国产精品无遮挡| 亚洲乱码国产乱码精品精小说| 一区二区三区久久| 视频一区中文字幕国产| 精品一区二区成人精品| 国产91精品一区二区麻豆网站| 91蝌蚪国产九色| 欧美日韩第一区日日骚| 精品日韩在线观看| 国产精品入口麻豆九色| 亚洲激情成人在线| 日韩精品一级中文字幕精品视频免费观看 | 91久久精品一区二区三| 欧美日韩一本到| 日韩免费一区二区| 国产蜜臀97一区二区三区| 亚洲特级片在线| 午夜欧美大尺度福利影院在线看 | 日本精品视频一区二区| 欧美精品v国产精品v日韩精品| 精品裸体舞一区二区三区| 亚洲国产岛国毛片在线| 亚洲一区视频在线| 黑人巨大精品欧美一区| 99精品国产99久久久久久白柏| 欧美午夜精品久久久| www欧美成人18+| 尤物在线观看一区| 久久电影国产免费久久电影| av欧美精品.com| 欧美高清dvd| 国产日韩欧美高清在线| 一区二区激情视频| 狠狠狠色丁香婷婷综合久久五月| 91在线小视频| 日韩无一区二区| 中文无字幕一区二区三区| 亚洲成人av在线电影| 精久久久久久久久久久| 在线国产亚洲欧美| 久久一日本道色综合| 最好看的中文字幕久久| 美国欧美日韩国产在线播放 | av激情综合网| 欧美一二三四区在线| 亚洲男人都懂的| 激情丁香综合五月| 欧美日韩一区国产| 国产日韩欧美麻豆| 日韩影院精彩在线| 91色在线porny| 久久亚区不卡日本| 三级影片在线观看欧美日韩一区二区| 国产成人av影院| 日韩一级精品视频在线观看| 成人欧美一区二区三区白人| 蜜臂av日日欢夜夜爽一区| 91久久国产最好的精华液| 久久久噜噜噜久噜久久综合| 视频一区视频二区中文| 91在线云播放| 久久精品免费在线观看| 琪琪久久久久日韩精品| 欧洲一区二区三区免费视频| 国产欧美日韩综合| 美国欧美日韩国产在线播放| 欧美自拍偷拍一区| 亚洲国产精品黑人久久久| 美女视频免费一区| 欧美色视频一区| 亚洲精品视频免费看| 亚洲乱码国产乱码精品精的特点| 国产成人午夜电影网| 日韩欧美你懂的| 性做久久久久久久久| 91丝袜美腿高跟国产极品老师| 久久久www成人免费无遮挡大片 | 日韩制服丝袜先锋影音|